Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

De novo mutations producing unstable hemoglobins or hemoglobins M

I. Establishment of a Depository and use of data to test for an association of de novo mutation with advanced parental age

  • 35 Accesses

  • 12 Citations


Hemoglobins M and unstable hemoglobins cause clinical syndromes that are transmitted in autosomal dominant fashion. Pedigrees of 50 probands with de novo mutations producing unstable Hb disease or Hb M disease were compiled. Cases were ascertained (1) by screening the relevant literature published from 1950 through 1980 and (2) through personal communication. Additional pedigree data on several published cases were collected, and a depository containing all available information rekated to de novo Hb mutants was established. The 50 probands were born in 14 countries between 1922 and 1976. Paternity was tested in 36% of the cases, and no instance of false paternity was noted.

The data were used to test for an association of advanced parental age with the appearance of de novo mutants. Paternal ages at the probands' births ranged from 20 to 50 years, with a mean of 32.7 years. Maternal ages ranged from 18 to 43 years, with a mean of 28.5 years. For each year and country (or, where necessary, for the nearest possible year and/or a demographically similar country), the cumulative frequency distributions of the ages of parents who had a child in that country and year were computed; the ages of each proband's father and mother were then expressed as percentiles on these distributions. The distribution of paternal age percentiles was shifted toward the upper end of the range, with 11 of the 50 paternal ages falling between the 90th and 100th percentiles. The distribution of maternal age percentiles was more complex, with one peak (10 of 50 ages) falling between the 30th and 40th percentiles and a second peak (10 of 50 ages), between the 90th and 100th percentiles. These distributions, though suggestive of an association of advanced parental age and the appearance of de novo mutations that cause unstable Hb disease or methemoglobinemic cyanosis, were not significantly different from those uniform distributions expected in the absence of a parental age effect.

This is a preview of subscription content, log in to check access.


  1. Blank CE (1960) Apert's syndrome (a type of acrocephalosyndactyly) —observations on a British series of 39 cases. Ann Hum Genet 24: 151–164

  2. Borberg A (1951) Clinical and genetic investigations into tuberous sclerosis and Recklinghausen's neurofibromatosis. Munksgaard, Copenhagen

  3. Bunn HF, Bradley TB, Davis WE, Drysdale JW, Burke JF, Beck WS, Laver MB (1972) Structural and functional studies on hemoglobin Bethesda (a 2β 2 145His ), a variant associated with compensatory erythrocytosis. J Clin Invest 51:2299–2309

  4. Bunn HF, Forget BG, Ranney HM (1977) Human hemoglobins. Saunders, Philadelphia

  5. Erickson JD, Cohen MM (1974) A study of parental age effects on the occurrence of fresh mutations for the Apert syndrome. Ann Hum Genet 38:89–96

  6. Haldane JBS (1947) The mutation rate of the gene for hemophilia and its segregation ratio in males and females. Ann Eugen (Lond) 13: 262–271

  7. International Hemoglobin Information Center (1977a) Variants of the alpha chain. Hemoglobin 1:603–618

  8. International Hemoglobin Information Center (1977b) Variants of the beta chain. Hemoglobin 1:708–733

  9. International Hemoglobin Information Center (1977c) Variant lists. Hemoglobin 1:887–897

  10. International Hemoglobin Information Center (1977c) Variant lists. Hemoglobin 1:708–733

  11. Lehmann H, Kynoch PAM (1976) Human haemoglobin variants and their characteristics. North-Holland, Amsterdam

  12. Murdoch JL, Walker BA, Hall JG, Abbey H, Smith KK, McKusick VA (1970) Achondroplasia—a genetic and statistical survey. Ann Hum Genet 33:227–244

  13. Murdoch JL, Walker BA, McKusick VA (1972) Parental age effects on the occurrence of new mutations for the Marfan syndrome. Ann Hum Genet 35:331–336

  14. Pellie C, Briard M-L, Feingold J, Frezal J (1977) Parental age in retinoblastoma. Humangenetik 20:59–62

  15. Penrose LS (1955) Parental age and mutation. Lancet II:312

  16. Penrose LS (1957) Parental age in achondroplasia and mongolism. Am J Hum Genet 9:167–169

  17. Rogers JG, Chase GA (1979) Paternal age effect in fibrodysplasia ossificans progressiva. J Med Genet 16:147–148

  18. Stamatoyannopoulos G (1972) The molecular basis of hemoglobin disease. Ann Rev Genet 6:47–70

  19. Stamatoyannopoulos G, Nute PE (1974) Genetic control of haemoglobins. Clin Haematol 3:251–287

  20. Stamatoyannopoulos G, Nute PE (1980) Announcement: de novo hemoglobin mutants. Hemoglobin 4:821–822

  21. Tunte W, Becker PE, von Knorre G (1967) Zur Genetik der Myositis ossificans progressiva. Humangenetik 4:320–351

  22. Vogel F, Rathenberg R (1975) Spontaneous mutations in man. Adv Hum Genet 5:223–318

References to Table 1

  1. Opfell RW, Lorkin PA, Lehmann H (1968) Hereditary non-spherocytic haemolytic anaemia with post-splenectomy inclusion bodies and pigmenturia caused by an unstable haemoglobin Santa Ana-β88 (F4) leucine→proline. Med Genet 5:292–297

  2. Fairbanks VF, Opfell RW, Burgert EO Jr (1969) Three families with unstable hemoglobinopathies (Köln, Olmsted and Santa Ana) causing hemolytic anemia with inclusion bodies and pigmenturia. Am J Med 46:344–359

  3. Schneider RG, Ueda S, Alperin JB, Brimhall B, Jones RT (1969) Hemoglobin Sabine beta 91 (F7) Leu→Pro: an unstable variant causing severe anemia with inclusion bodies. N Engl J Med 280: 739–745

  4. Miller DR, Weed RI, Stamatoyannopoulos G, Yoshida A (1971) Hemoglobin Köln disease occurring as a fresh mutation: erythrocyte metabolism and survival. Blood 38:715–729

  5. Huisman THJ, Brown AK, Efremov GD, Wilson JB, Reynolds CA, Uy R, Smith LL (1971) Hemoglobin Savannah (B6(24) β-glycine→valine): an unstable variant causing anemia with inclusion bodies. J Clin Invest 50:650–659

  6. Koler RD, Jones RT, Bigley RH, Litt M, Lovrien E, Brooks R, Lahey ME, Fowler R (1973) Hemoglobin Casper: β106 (G8) Leu→Pro: a contemporary mutation. Am J Med 55:549–558

  7. Honig GR, Green D, Shamsuddin M, Vida LN, Mason RG, Gnarra DJ, Maurer HS (1973) Hemoglobin Abraham Lincoln, β32 (B14) leucine→proline: an unstable variant producing severe hemolytic disease. J Clin Invest 52:1746–1755

  8. Schneider RG, Hettig RA, Bilunos M, Brimhall B (1976) Hemoglobin Baylor a 2β281 (EF5) Leu→ Arg—an unstable mutant with high oxygen affinity. Hemoglobin 1:85–96

  9. Smiley RK, Gravely ME, Wilson JB, Huisman THJ (1978) Hemoglobin Louisville (β42 (CD1) Phe→ Leu) occurring as a fresh mutation in a Canadian woman. Hemoglobin 2:89–90

  10. Wong SC, Ali MAM, Pai M, Barr RD (1980) A new case of the unstable haemoglobin Genova (a 2β2 28 (B10) Leu→Pro) in Canada: as a result of sporadic mutation and causing Heinz body hemolytic anaemia. Acta Haematol 63:222–225

  11. Dacie JV, Shinton NK, Gaffney PJ Jr, Carrell RW, Lehmann H (1967) Haemoglobin Hammersmith (β42 (CD1) Phe→Ser). Nature 216:663–665

  12. Carrell RW, Lehmann H (1969) The unstable haemoglobin haemolytic anaemias. Semin Hematol 6:116–132

  13. Steadman JH, Yates A, Huehns ER (1970) Idiopathic Heinz body anaemia: Hb-Bristol (β57 (E11) Val→Asp). Br J Haematol 18: 435–446

  14. Hyde RD, Hall MD, Wiltshire BG, Lehmann H (1972) Haemoglobin Southampton, β106 (G8) Leu→Pro: an unstable variant producing severe haemolysis. Lancet II:1170–1172

  15. Gordon-Smith EC, Dacie JV, Blecher TE, French EA, Wiltshire BG, Lehmann H (1973) Haemoglobin Nottingham, βFG5 (98) Val→Gly: a new unstable haemoglobin producing severe haemolysis. Proc R Soc Med 66:507–508

  16. Rosa J, Labie D, Wajcman H, Boigne JM, Cabannes R, Bierme R, Ruffie J (1969) Haemoglobin I Toulouse: β66 (E10) Lys→Glu: a new abnormal haemoglobin with a muration localized on the E10 porphyrin surrounding zone. Nature 223:190–191

  17. Cohen Solal M, Thillet J, Gaillardon J, Rosa J (1972) Functional properties of hemoglobin Saint Etienne: a variant carrying heme only on α chains. Rev Eur Études Clin Biol 17:988–993

  18. Cohen-Solal M, Seligmann M, Thillet J, Rosa J (1973) Haemoglobin Saint Louis β28 (b10) leucine→glutamine: a new unstable haemoglobin only present in a ferri form. FEBS Lett 33:37–41

  19. Cohen Solal M, Labie D (1973) A new case of hemoglobin Genova a 2β 2 28 (B 10) Leu→Pro : further studies on the mechanism of instability and defective synthesis. Biochim Biophys Acta 295:67–76

  20. Wajcman H, Krishnamoorthy R, Gacon G, Elion J, Allard C, Labie D (1976) A new hemoglobin variant involving the distal histidine: Hb Bicêtre (β63 (E7) His→Pro). J Mol Med 1:187–197

  21. Garel MC, Blouquit Y, Rosa J (1975) Hemoglobin Castilla β32 (B14) Leu→Arg; a new unstable variant producing severe hemolytic disease. FEBS Lett 58:145–148

  22. Jones RT, Brimhall B, Huisman THJ, Kleihauer E, Betke K (1966) Hemoglobin Freiburg: abnormal hemoglobin due to deletion of a single amino acid residue. Science 154:1024–1027

  23. Hollán SR, Szelényi JG, Miltényi M, Charlesworth D, Lorkin PA, Lehmann H (1970) Unstable haemoglobin disease caused by Hb Santa Ana-β88 (F4) Leu→Pro. Haematologia 4:141–155

  24. Aksoy M, Erdem S, Efremov GD, Wilson JB, Hisman THJ, Schroeder WA, Shelton JR, Shelton JB, Ulitin ON, Müftüôglu A (1972) Hemoglobin Istanbul: substitution of glutamine for histidine in a proximal histidine (F8 (92)β). J Clin Invest 51:2380–2387

  25. Idelson LI, Didkowsky NA, Casey R, Lorkin PA, Lehmann H (1974) New unstable haemoglobin (Hb Moscva, β24 (B4) Gly→ Asp) found in the USSR. Nature 249:768–770

  26. Idelson LI, Didkoysky NA, Filippova AV, Casey R, Kynoch PAM, Leyman H (1975) Haemoglobin Volga, β27, (B9) Ala→Asp, a new highly unstable haemoglobin with a suppressed charge. FEBS Lett 58:122–125

  27. Carrell RW, Owen MC (1971) A new approach to haemoglobin variant identification: haemoglobin Christchurch β71 (E15) phenylalanine→serine. Biochim Biophys Acta 236:507–511

  28. Brennan SO, Ekert H, Tauro G, Carrell RW (1976) Haemoglobin Volga: a variant producing congenital haemolytic anaemia. N Z Med J 83:162

  29. Shibata S, Iuchi I, Miyaji T, Ueda S, Takeda I (1963) Hemolytic disease associated with the production of abnormal hemoglobin and intraerythrocytic Heinz bodies. Acta Haematol Jpn 26:164–173

  30. Ohba Y, Miyaji T, Matsuoka M, Sugiyama K, Suzuki T, Sugiura T (1977) Hemoglobin Mizuho or beta 68 (E12) leucine→proline, an unstable variant associated with severe hemolytic anemia. Hemoglobin 1:467–477

  31. Ohba Y, Miyaji T, Matsuoka M, Yamaguchi K, Yonemitsu H, Ishii T, Shibata S (1975) Hemoglobin Chiba: Hb Hammersmith in a Japanese girl. Acta Haematol Jpn 38:53–58

References to Table 2

  1. Pisciotta AV, Ebbe SN, Hinz JE (1959) Clinical and laboratory features of two variants of methemoglobin M disease. J Lab Clin Med 54:73–87

  2. Heller P, Weinstein HG, Yakulis VJ, Rosenthal IM (1962) Hemoglobin MKankakee, a new variant of hemoglobin M. Blood 20:287–301

  3. Stamatoyannopoulos G, Nute PE, Giblett E, Detter J, Chard R (1976) Haemoglobin M Hyde Park occurring as a fresh mutation: diagnostic, structural, and genetic considerations. J Med Genet 13:142–147

  4. Krishnamporthy R, Wajcman H, Labie D, Backef CH, Tron P (1976) A case of hemoglobin M Boston. New data about valency hybrids brought by isoelectrofocusing study. Biomedicine 25:151–154

  5. Kissin C, Collombel C, Baltassat P, Freycon F, Cotte J (1971) Un cas de méthémoglobinose M. Nouv Rev Fr Hematol 11:17–23

  6. Stavem P, Strömme J, Lorkin PA, Lehmann H (1972) Haemoglobin M Saskatoon with slight constant haemolysis, markedly increased by sulphonamides. Scand J Haematol 9:566–571

  7. Becroft DMO, Douglas R, Carrell RW, Lehmann H (1968) Haemoglobin MHyde Park: a hereditary methaemoglobinaemia in a Caucasian child. NZ Med J 68:72–76

  8. Kimura N, Nishimoto S, Nawata Y, Mori F, Kodama S, Nakakura S (1960) Hemoglobin M disease: a case report. Jpn Heart J 1:446–465

  9. Hayashi A, Yamamura Y (1964) Hemoglobin MOsaka, a new variant of hemoglobin M. Jpn J Hum Genet 9:87–94

Download references

Author information

Correspondence to G. Stamatoyannopoulos.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Stamatoyannopoulos, G., Nute, P.E. & Miller, M. De novo mutations producing unstable hemoglobins or hemoglobins M. Hum Genet 58, 396–404 (1981). https://doi.org/10.1007/BF00282822

Download citation


  • Marfan Syndrome
  • Achondroplasia
  • Myositis Ossificans
  • Abnormal Hemoglobin
  • Heinz Body